{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T13:39:32Z","timestamp":1790602772976,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"S2","license":[{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1038\/sj.bjc.6602063","type":"journal-article","created":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T07:11:23Z","timestamp":1094022683000},"page":"S18-S23","source":"Crossref","is-referenced-by-count":122,"title":["Interstitial lung disease associated with drug therapy"],"prefix":"10.1038","volume":"91","author":[{"given":"P","family":"Camus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Kudoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Ebina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2004,8,31]]},"reference":[{"key":"BF6602063_CR1","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1148\/radiol.2243011236","volume":"224","author":"M Akira","year":"2002","unstructured":"Akira M, Ishikawa H, Yamamoto S (2002) Drug-induced pneumonitis: thin-section CT findings in 60 patients. Radiology 224: 852\u2013860","journal-title":"Radiology"},{"key":"BF6602063_CR2","unstructured":"AstraZeneca and Iressa Expert Committee (2003) Final report on interstitial lung disease (ILD) related to gefitinib (Iressa\u00ae Tablet 250)"},{"key":"BF6602063_CR3","first-page":"385","volume":"52","author":"G Aviram","year":"2001","unstructured":"Aviram G, Yu E, Tai P, Lefcoe MS (2001) Computed tomography to assess pulmonary injury associated with concurrent chemo-radiotherapy for inoperable non-small cell lung cancer. Can Assoc Radiol J 52: 385\u2013391","journal-title":"Can Assoc Radiol J"},{"issue":"Suppl 32","key":"BF6602063_CR4","doi-asserted-by":"crossref","first-page":"93s","DOI":"10.1183\/09031936.01.18s320093","volume":"18","author":"P Camus","year":"2001","unstructured":"Camus P, Foucher P, Bonniaud P, Ask K (2001) Drug-induced infiltrative lung disease. Eur Resp J 18(Suppl 32): 93s\u2013100s","journal-title":"Eur Resp J"},{"key":"BF6602063_CR5","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1053\/crad.2001.0792","volume":"57","author":"JR Cleverley","year":"2002","unstructured":"Cleverley JR, Screaton NJ, Hiorns MP, Flint JDA, M\u00fcller NL (2002) Drug-induced lung disease: high-resolution CT and histological findings. Clin Radiol 57: 292\u2013299","journal-title":"Clin Radiol"},{"key":"BF6602063_CR6","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.2214\/ajr.175.4.1751019","volume":"175","author":"SJ Ellis","year":"2000","unstructured":"Ellis SJ, Cleverley JR, M\u00fcller NL (2000) Drug-induced lung disease: high-resolution CT findings. AJR Am J Roentgenol 175: 1019\u20131024","journal-title":"AJR Am J Roentgenol"},{"key":"BF6602063_CR7","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1053\/sroe.2002.0000","volume":"37","author":"JJ Erasmus","year":"2002","unstructured":"Erasmus JJ, McAdams HP, Rossi SE (2002) Drug-induced lung injury. Semin Roentgenol 37: 72\u201381","journal-title":"Semin Roentgenol"},{"key":"BF6602063_CR8","unstructured":"ESMO (2003) Minimum clinical recommendations for diagnosis, treatment and follow-up of non-small-cell lung cancer (NSCLC). Available at http:\/\/www.esmo.org\/reference\/referenceGuidelines\/pdf\/new_pdf\/ESMO_03_NSCLC.pdf Accessed 9\/03"},{"issue":"Suppl 2","key":"BF6602063_CR9","doi-asserted-by":"publisher","first-page":"S70","DOI":"10.1016\/S0169-5002(03)91898-8","volume":"41","author":"B Forsythe","year":"2003","unstructured":"Forsythe B, Faulkner K (2003a) Clinical experience with gefitinib (\u2018Iressa\u2019, ZD1839): an overview of safety and tolerability. Lung Cancer 41(Suppl 2): S70\u2013S71, (abstr. O-240)","journal-title":"Lung Cancer"},{"key":"BF6602063_CR10","unstructured":"Forsythe B, Faulkner K (2003b) Safety and tolerability of gefitinib (\u2018Iressa\u2019, ZD1839) in advanced NSCLC: overview of clinical experience. Poster presented at the ERS, Vienna, Austria, September 27\u2013October 1, Poster number P327"},{"key":"BF6602063_CR11","unstructured":"Foucher P, Camus P, the GEPPI (2003) Pneumotox on line. The drug-induced lung diseases. Available at http:\/\/www.pneumotox.com\/ Accessed 10\/03"},{"issue":"Suppl 2","key":"BF6602063_CR12","doi-asserted-by":"publisher","first-page":"S247","DOI":"10.1016\/S0169-5002(03)92582-7","volume":"41","author":"M Fukuoka","year":"2003","unstructured":"Fukuoka M, Kris M, Giaccone G, Lynch T, Nakagawa K, Kelly K, Wolf M, McPartlane A, Kay A, Fandi A (2003) Phase II trials of gefitinib (\u2018Iressa\u2019, ZD1839): rapid and durable objective responses in patients with advanced non-small-cell lung cancer (IDEAL 1 and IDEAL 2). Lung Cancer 41(Suppl 2): S247\u2013S248, (abstr. P-615)","journal-title":"Lung Cancer"},{"key":"BF6602063_CR13","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1378\/chest.107.6.1763","volume":"107","author":"RJ Gonzalez-Rothi","year":"1995","unstructured":"Gonzalez-Rothi RJ, Zander DS, Ros PR (1995) Fluoxetine hydrochloride (Prozac)-induced pulmonary disease. Chest 107: 1763\u20131765","journal-title":"Chest"},{"key":"BF6602063_CR14","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1034\/j.1399-3003.2000.15b25.x","volume":"15","author":"S Imokawa","year":"2000","unstructured":"Imokawa S, Colby TV, Leslie KO, Helmers RA (2000) Methotrexate pneumonitis: review of the literature and histopathological findings in nine patients. Eur Resp J 15: 373\u2013381","journal-title":"Eur Resp J"},{"key":"BF6602063_CR15","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0140-6736(03)12190-3","volume":"361","author":"A Inoue","year":"2003","unstructured":"Inoue A, Saijo Y, Maemondo M, Gomi K, Tokue Y, Kimura Y, Ebina M, Kikuchi T, Moriya T, Nukiwa T (2003) Severe acute interstitial pneumonia and gefitinib. Lancet 361: 137\u2013139","journal-title":"Lancet"},{"key":"BF6602063_CR16","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1001\/jama.290.16.2149","volume":"290","author":"MG Kris","year":"2003","unstructured":"Kris MG, Natale RB, Herbst RS, Lynch Jr TJ, Prager D, Belani CP, Schiller JH, Kelly K, Spiridonidis H, Sandler A, Albain KS, Cella D, Wolf MK, Averbuch SD, Ochs JJ, Kay AC (2003) Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer.A randomized trial. JAMA 290: 2149\u20132158","journal-title":"JAMA"},{"key":"BF6602063_CR17","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1200\/JCO.1996.14.5.1649","volume":"14","author":"H Kunitoh","year":"1996","unstructured":"Kunitoh H, Watanabe K, Onoshi T, Furuse K, Niitani H, Taguchi T (1996) Phase II trial of docetaxel in previously untreated advanced non-small-cell lung cancer: a Japanese cooperative study. J Clin Oncol 14: 1649\u20131655","journal-title":"J Clin Oncol"},{"key":"BF6602063_CR18","unstructured":"Lilly (2003) Gemcitabine prescribing information. Available at http:\/\/pi.lilly.com\/gemzar.pdf Accessed 4\/23\/99"},{"key":"BF6602063_CR19","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1023\/A:1008226416896","volume":"8","author":"M Merad","year":"1997","unstructured":"Merad M, Le Cesne A, Baldeyrou P, Mesurolle B, Le Chevalier T (1997) Docetaxel and interstitial pulmonary injury. Ann Oncol 8: 191\u2013194","journal-title":"Ann Oncol"},{"key":"BF6602063_CR20","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1378\/chest.123.6.2146","volume":"123","author":"M Oddo","year":"2003","unstructured":"Oddo M, Liaudet L, Lepori M, Broccard AF, Schaller MD (2003) Relapsing acute respiratory failure induced by minocycline. Chest 123: 2146\u20132148","journal-title":"Chest"},{"key":"BF6602063_CR21","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1056\/NEJMoa011954","volume":"346","author":"JH Schiller","year":"2002","unstructured":"Schiller JH, Harrington D, Belani CP, Langer C, Sandler A, Krook J, Zhu J, Johnson DH, The Eastern Cooperative Oncology Group (2002) Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med 346: 92\u201398","journal-title":"N Engl J Med"},{"key":"BF6602063_CR22","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1001\/archinte.1994.00420060122013","volume":"154","author":"A Spickard III","year":"1994","unstructured":"Spickard III A, Hirschmann JV (1994) Exogenous lipoid pneumonia. Arch Intern Med 154: 686\u2013692","journal-title":"Arch Intern Med"},{"key":"BF6602063_CR23","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1054\/bjoc.2001.2071","volume":"85","author":"G-S Wang","year":"2001","unstructured":"Wang G-S, Yan K-Y, Perng R-P (2001) Life-threatening hypersensitivity pneumonitis induced by docetaxel (taxotere). Br J Cancer 85: 1247\u20131250","journal-title":"Br J Cancer"},{"key":"BF6602063_CR24","first-page":"225","volume":"22","author":"N Yamamoto","year":"2003","unstructured":"Yamamoto N, Yamada Y, Shimoyama T, Murakami H, Horiike A, Fujisaka Y, Takayama K, Sakamoto T, Hoshida M, Tamura T (2003) A phase I study of erlotinib HCI in Japanese patients with various types of solid tumors. Proc Am Soc Clin Oncol 22: 225 (abstr. 903)","journal-title":"Proc Am Soc Clin Oncol"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6602063.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6602063","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6602063.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T13:27:31Z","timestamp":1734528451000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6602063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":24,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["BF6602063"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6602063","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,8]]}}}